Winifred L. Swan, SVP and General Counsel at NxStage Medical, Inc. (NXTM), sold 2,500 shares at $14.07 ($35K) on 2016-02-16, disclosed to the SEC on 2016-02-18.
Scheduled sale ($35k) by SVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| NXTM | SELL | 2017-12-21 | $89K | — | Filing → |
| NXTM | SELL | 2017-11-15 | $90K | — | Filing → |
| NXTM | SELL | 2017-10-23 | $96K | — | Filing → |